Insights Into The $50+ Billion Urology Care Devices & Platforms Market 2025-2030 Featuring Boston Scientific, Olympus, Medtronic, Coloplast, And BD Among Other Industry Giants

(MENAFN- GlobeNewsWire - Nasdaq) The urology care devices and platforms market offers opportunities in advanced diagnostics, minimally invasive procedures, and digital health innovations. Collaboration and technology integration are key, with growth potential in Asia-Pacific and Latin America.

Dublin, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The "Urology Care Devices & Platforms Market by Product Type (Diagnostics, Endoscopes, Imaging), Application (Benign Prostatic Hyperplasia, Kidney Cancer, Kidney Stone Management), End User, Procedure Type, Technology - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering.

The urology care devices and platforms market is advancing rapidly as new clinical practices and patient-centered technologies drive transformation. Senior decision-makers now face complex choices shaped by evolving patient expectations, regulatory demands, and technology adoption priorities in delivering high-quality urological care.

Market Snapshot: Urology Care Devices & Platforms Market Outlook

The Urology Care Devices & Platforms Market grew from USD 47.74 billion in 2024 to USD 50.59 billion in 2025. It is expected to continue growing at a CAGR of 5.93%, reaching USD 67.46 billion by 2030. This sustained expansion reflects rising demand for advanced diagnostic and therapeutic solutions, increased prevalence of chronic urologic disorders, and broader adoption of digital health innovations. Technological breakthroughs and new care models are redefining the competitive landscape, compelling leaders to realign strategies across global regions and operational domains.

Scope & Segmentation: Navigating Critical Market Segments

• Product Types: Diagnostics (biomarker assays, pH meters, urinary flow meters, urodynamic systems), Endoscopes (cystoscopes, nephroscopes, ureteroscopes), Imaging (CT scanning, MRI, ultrasound, X-ray), Lithotripsy (extracorporeal shockwave, laser, pneumatic, ultrasonic), Urinary Catheters (condom, Foley, intermittent, nephrostomy, ureteral), Urinary Stents (prostatic, ureteral, urethral).
• Applications: Benign prostatic hyperplasia, kidney cancer (renal cell carcinoma, transition cell carcinoma, Wilms tumor), kidney stone management (calcium, cystine, struvite, uric acid stones), overactive bladder (idiopathic, neurogenic), prostate cancer (localized, metastatic, recurrent), urethral stricture (iatrogenic, idiopathic, traumatic), urinary incontinence (mixed, overflow, stress, urge), urinary tract infection (complicated, uncomplicated).
• End Users: Ambulatory surgical centers, clinics, diagnostic centers, home care, hospitals.
• Procedure Types: Invasive (catheterization, open surgery), minimally invasive (endoscopic, laparoscopic, percutaneous procedures), non-invasive (conservative management, external shockwave therapy, imaging).
• Technologies: Electrohydraulic (high frequency, standard), laser (CO2, greenlight, holmium, thulium), magnetic resonance (MR spectroscopy, MRI-guided), optical (fluorescence, narrow band, white light imaging), pneumatic (ballistic, vibratory), RF (bipolar, monopolar), ultrasonic (high and low intensity).
• Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and additional countries), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
• Key Companies: Boston Scientific Corporation, Olympus Corporation, Medtronic plc, Coloplast A/S, Becton, Dickinson and Company, Teleflex Incorporated, ConvaTec Group plc, Intuitive Surgical, Inc., Stryker Corporation, Johnson & Johnson.

Key Takeaways: Strategic Insights for Decision-Makers

• Pace of innovation is accelerating, with device design, data analytics, and integrated platforms enabling earlier diagnosis and minimally invasive interventions.
• Collaboration across manufacturers, clinicians, and technology firms is central to building interoperable solutions, supporting seamless care transitions and improved patient experiences.
• Minimally invasive and non-invasive therapies are gaining traction, reducing postoperative complications and enabling more patient-centric outpatient care settings.
• Digital transformation is changing clinician workflows through AI-enhanced imaging, remote monitoring via sensors and mobile applications, and improved longitudinal care management.
• Emergent market players and established manufacturers are diversifying portfolios by focusing on clinical sub-segments and geographic growth, notably in Asia-Pacific and Latin America.
• Personalization of care, regulatory engagement, and evidence-based reimbursement strategies are becoming crucial to long-term market positioning and commercial success.

Tariff Impact: Responding to Evolving U.S. Trade Dynamics

New U.S. tariffs on imported urology devices in 2025 are reshaping supply chain strategies, elevating landed costs, and prompting organizations to reassess sourcing and manufacturing locations. Medical device manufacturers and providers are actively seeking alternative suppliers, revising procurement models, and exploring domestic and nearshoring options to sustain operational resilience. The regulatory environment is driving renewed attention to quality and efficiency, influencing pricing strategies and partnership opportunities.

Methodology & Data Sources

This market analysis is grounded in in-depth interviews with clinical leaders, procurement professionals, and industry executives. Primary insights are triangulated with secondary research from peer-reviewed journals, regulatory filings, and market reports. An expert validation process ensures alignment with current industry perspectives and the accuracy of technology trends.

Why This Report Matters

• Empowers strategic planning by mapping technology evolution, stakeholder collaborations, and shifts in regional demand within urology care devices and platforms.
• Delivers actionable insights for navigating regulatory, reimbursement, and procurement challenges in a dynamic market landscape.
• Equips leadership with a robust foundation to identify growth opportunities, mitigate supply chain risks, and foster patient-centered innovation.

Key Attributes

Report Attribute	Details
No. of Pages	185
Forecast Period	2025-2030
Estimated Market Value (USD) in 2025	$50.59 Billion
Forecasted Market Value (USD) by 2030	$67.46 Billion
Compound Annual Growth Rate	5.9%
Regions Covered	Global

Key Topics Covered
1. Preface
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI-driven diagnostics for early detection of prostate cancer and kidney stones
5.2. Adoption of teleurology platforms to deliver remote urological consultations and patient monitoring
5.3. Development of minimally invasive robotic-assisted surgical systems tailored to complex urological procedures
5.4. Growth of wearable urinary incontinence monitoring devices offering real-time analytics for treatment optimization
5.5. Launch of advanced smart catheter solutions designed to reduce infections and enhance patient comfort
5.6. Expansion of point-of-care molecular testing platforms enabling rapid urinary tract infection diagnosis
5.7. Utilization of cloud-based patient management software for integrated urology care coordination and analytics
6. Market Insights
6.1. Porter's Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025

8. Urology Care Devices & Platforms Market, by Product Type
8.1. Introduction
8.2. Diagnostics
8.2.1. Biomarker Assays
8.2.2. PH Meters
8.2.3. Urinary Flow Meters
8.2.4. Urodynamic Systems
8.3. Endoscopes
8.3.1. Cystoscopes
8.3.2. Nephroscopes
8.3.3. Ureteroscopes
8.4. Imaging
8.4.1. CT Scanning Systems
8.4.2. MRI Systems
8.4.3. Ultrasound Systems
8.4.4. X Ray Systems
8.5. Lithotripsy
8.5.1. Extracorporeal Shockwave Lithotripsy
8.5.2. Laser Lithotripsy
8.5.3. Pneumatic Lithotripsy
8.5.4. Ultrasonic Lithotripsy
8.6. Urinary Catheters
8.6.1. Condom Catheters
8.6.2. Foley Catheters
8.6.3. Intermittent Catheters
8.6.4. Nephrostomy Catheters
8.6.5. Ureteral Catheters
8.7. Urinary Stents
8.7.1. Prostatic Stents
8.7.2. Ureteral Stents
8.7.3. Urethral Stents
9. Urology Care Devices & Platforms Market, by Application
9.1. Introduction
9.2. Benign Prostatic Hyperplasia
9.3. Kidney Cancer
9.3.1. Renal Cell Carcinoma
9.3.2. Transition Cell Carcinoma
9.3.3. Wilms Tumor
9.4. Kidney Stone Management
9.4.1. Calcium Stones
9.4.2. Cystine Stones
9.4.3. Struvite Stones
9.4.4. Uric Acid Stones
9.5. Overactive Bladder
9.5.1. Idiopathic
9.5.2. Neurogenic
9.6. Prostate Cancer
9.6.1. Localized
9.6.2. Metastatic
9.6.3. Recurrent
9.7. Urethral Stricture
9.7.1. Iatrogenic
9.7.2. Idiopathic
9.7.3. Traumatic
9.8. Urinary Incontinence
9.8.1. Mixed Incontinence
9.8.2. Overflow Incontinence
9.8.3. Stress Incontinence
9.8.4. Urge Incontinence
9.9. Urinary Tract Infection
9.9.1. Complicated
9.9.2. Uncomplicated
10. Urology Care Devices & Platforms Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Diagnostic Centers
10.5. Home Care
10.6. Hospitals
11. Urology Care Devices & Platforms Market, by Procedure Type
11.1. Introduction
11.2. Invasive
11.2.1. Catheterization Interventions
11.2.2. Open Surgery
11.3. Minimally Invasive
11.3.1. Endoscopic Procedures
11.3.2. Laparoscopic Procedures
11.3.3. Percutaneous Procedures
11.4. Non Invasive
11.4.1. Conservative Management
11.4.2. External Shockwave Therapy
11.4.3. Imaging
12. Urology Care Devices & Platforms Market, by Technology
12.1. Introduction
12.2. Electrohydraulic
12.2.1. High Frequency Electrohydraulic
12.2.2. Standard Electrohydraulic
12.3. Laser
12.3.1. CO2 Laser
12.3.2. Greenlight Laser
12.3.3. Holmium Laser
12.3.4. Thulium Laser
12.4. Magnetic Resonance
12.4.1. MR Spectroscopy
12.4.2. MRI Guided MR
12.5. Optical
12.5.1. Fluorescence Optical
12.5.2. Narrow Band Imaging
12.5.3. White Light Optical
12.6. Pneumatic
12.6.1. Ballistic Pneumatic
12.6.2. Vibratory Pneumatic
12.7. RF
12.7.1. Bipolar RF
12.7.2. Monopolar RF
12.8. Ultrasonic
12.8.1. High Intensity Ultrasonic
12.8.2. Low Intensity Ultrasonic
13. Americas Urology Care Devices & Platforms Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Urology Care Devices & Platforms Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Urology Care Devices & Platforms Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis

The major companies profiled in this Urology Care Devices & Platforms market report include:

• Boston Scientific Corporation
• Olympus Corporation
• Medtronic plc
• Coloplast A/S
• Becton, Dickinson and Company
• Teleflex Incorporated
• ConvaTec Group plc
• Intuitive Surgical, Inc.
• Stryker Corporation
• Johnson & Johnson

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Urology Care Devices & Platforms Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN04092025004107003653ID1110016838